Results 31 to 40 of about 82,057 (154)

Chronic Idiopathic Constipation in Adults: A Review on Current Guidelines and Emerging Treatment Options

open access: yesClinical and Experimental Gastroenterology, 2021
Gabrio Bassotti,1 Paolo Usai Satta,2 Massimo Bellini3 1Gastroenterology & Hepatology Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy; 2Gastrointestinal Unit, “G. Brotzu” Hospital, Cagliari, Italy; 3Gastrointestinal Unit,
Bassotti G, Usai Satta P, Bellini M
doaj  

Some aspects of the treatment of constipation in therapeutic outpatient practice

open access: yesЛечащий Врач, 2023
Background. Constipation is one of the most common complaints and reasons for seeking medical help. Difficulties in bowel movements, pain and discomfort experienced during this process, and rare and scanty stools significantly reduce the quality of life ...
A. A. Stremoukhov, N. L. Vlasova
doaj   +1 more source

A comparative analysis of the prevalence of medicine classes and polypharmacy between community‐dwelling and residential aged care populations in Western Australia

open access: yesJournal of Pharmacy Practice and Research, EarlyView.
Abstract Background Polypharmacy is a global issue, particularly among residential aged care home (RACH) residents with multimorbidity and complex care needs. However, population‐level evidence on longitudinal trends and comparisons with community‐dwelling (CD) older adults remains limited.
David Lim   +4 more
wiley   +1 more source

Gut microbiome dysbiosis across early Parkinson’s disease, REM sleep behavior disorder and their first-degree relatives

open access: yesNature Communications, 2023
The microbiota-gut-brain axis has been suggested to play an important role in Parkinson’s disease (PD). Here we performed a cross-sectional study to profile gut microbiota across early PD, REM sleep behavior disorder (RBD), first-degree relatives of RBD (
Bei Huang   +18 more
doaj   +1 more source

The Gut–Brain Axis in Parkinson's Disease: From Clinical Observation toward Mechanism‐Based Precision Medicine

open access: yesMovement Disorders, EarlyView.
Abstract Gastrointestinal dysfunction is increasingly recognized as a core feature of Parkinson's disease (PD), affecting quality of life, nutrition, medication response, and potentially the earliest stages of pathogenesis. This perspective traces the evolution of the gut from a neglected source of non‐motor symptoms to a central component of ...
Filip Scheperjans   +4 more
wiley   +1 more source

Pharmacologic Treatment of Chronic Constipation

open access: yesThe Korean Journal of Gastroenterology
Chronic constipation is a common disease that can impair the quality of life, with a prevalence of 14% globally and 16.5% in South Korea. Straining, hard stools, the sensation of incomplete evacuation, the sensation of anorectal blockage, and manual ...
Hoyoung Wang, Jung Won Lee
doaj   +1 more source

Gut commensal Enterocloster species host inoviruses that are secreted in vitro and in vivo

open access: yesMicrobiome, 2023
Background Bacteriophages in the family Inoviridae, or inoviruses, are under-characterized phages previously implicated in bacterial pathogenesis by contributing to biofilm formation, immune evasion, and toxin secretion.
Juan C. Burckhardt   +3 more
doaj   +1 more source

Emergencies in Amyotrophic Lateral Sclerosis

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Emergencies are frequent in people living with amyotrophic lateral sclerosis (pALS), especially as the disease progresses, and can necessitate urgent evaluation and intervention. Progressive weakness in ALS inevitably increases fall risk, making discussion of fall prevention strategies integral to caring for pALS.
S. Pinar Uysal   +9 more
wiley   +1 more source

Functional constipation in young children: causes, diagnostic criteria and therapeutic strategies

open access: yesМедицинский совет, 2018
The article gives a modern definition of constipation and working classification used in Pediatrics; frequency of defecation and qualitative characteristics of stool depending on age and type of feeding are presented.
N. M. Bogdanova
doaj   +1 more source

Changes in Gastrointestinal Symptoms Among Children With Cystic Fibrosis During 12 Months of Elexacaftor/Tezacaftor/Ivacaftor Therapy: A Swedish Multicentre Study

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim Elexacaftor/Tezacaftor/Ivacaftor (ETI) has markedly improved clinical outcomes in cystic fibrosis (CF). However, its effects on gastrointestinal (GI) function, nutrition and pancreatic enzyme therapy in children remain insufficiently described.
Marcus Svedberg   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy